RESEARCH / DISCOVERY
← Back to the library

[The dopamine agonist, lisuride, in the therapy of Parkinson disease].

[The dopamine agonist, lisuride, in the therapy of Parkinson disease].

Read the original publication

A plain-language reading has not been prepared for this paper yet.

Original abstract

The development of fluctuations in disability are a main problem of the levodopa long-term treatment in Parkinson's disease. The early combination of low doses of levodopa with a dopamine agonist as lisuride improves the symptoms of Parkinson's disease as much as a monotherapy but prevents the development of fluctuations in disability and dyskinesias at the same time.

Explore another example or bring your own paper

Pasted text and PDF extraction stay on this computer. The local guide explains terms and surfaces passages; rewriting requires a configured local model. Scanned PDFs need OCR first.

RECORD & PROVENANCE